Patent ID: 6867217
Filing Date: 2005-03-15
Classification: C07D

Abstract:
1. A compound having the Formula: or a pharmaceutically acceptable salt thereof, wherein; B is selected from the group consisting of hydrido, C2-C8 alkyl, C3-C8 alkenyl, C3-C8 alkynyl, and C2-C8 haloalkyl, wherein each member of group B is optionally substituted at any carbon up to and including 6 atoms from the point of attachment of B to A with one or more of the group consisting of R R A is selected from the group consisting of single covalent bond and (CH(R R R R R Z Q is aryl, wherein (a) a ring carbon in a first alpha position relative to the ring carbon at the point of attachment is optionally substituted by R R R Y  wherein D R Q R Q